A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients

Clinical trial NCT04116411 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04116411
Sponsor: Cecilia Soderberg-Naucler
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2019-09-04
Primary completion: 2027-09-16
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.